Evidence map›Paper›PMID 26637466›Full record

Trial reportBMC infectious diseases2015

The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome.

Joanna Jabłońska, Tomasz Pawłowski, Tomasz Laskus, Małgorzata Zalewska, Małgorzata Inglot, Sylwia Osowska, Karol Perlejewski, Iwona Bukowska-Ośko, Kamila Caraballo Cortes, Agnieszka Pawełczyk and 2 more

Erratum issuedAbstract readClinical Trial
In one paragraph

Trial report in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Joanna JabłońskaDepartment of Hepatology and Acquired Immunodeficiences, Medical University of Warsaw, Warsaw, Poland. joannaj108@hotmail.com.
Tomasz PawłowskiDivision of Psychotherapy and Psychosomatic Medicine, Wrocław Medical University, Wrocław, Poland. tomasz.pawlowski@am.wroc.pl.
Tomasz LaskusDepartment of Immunopathology of Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. tlaskus@yahoo.com.
Małgorzata ZalewskaDepartment of Infectious Diseases, Hepatology and Acquired Immune Deficiences, Wrocław Medical University, Wrocław, Poland. mzalewska@k.pl.
Małgorzata InglotDepartment of Infectious Diseases, Hepatology and Acquired Immune Deficiences, Wrocław Medical University, Wrocław, Poland. minglot@interia.pl.
Sylwia OsowskaDepartment of General Surgery and Clinical Nutrition, Medical University of Warsaw, Warsaw, Poland. sylwiao@hotmail.com.
Karol PerlejewskiDepartment of Immunopathology of Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. kperlejewski@wum.edu.pl.
Iwona Bukowska-OśkoDepartment of Immunopathology of Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. ibukowska@wum.edu.pl.
Kamila Caraballo CortesDepartment of Immunopathology of Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. kamila.caraballo@wum.edu.pl.
Agnieszka PawełczykDepartment of Immunopathology of Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. agnieszka.pawelczyk@wum.edu.pl.
Piotr ZąbekMunicipal Hospital of Infectious Diseases, Warsaw, Poland. pzabek@zakazny.pl.
Marek RadkowskiDepartment of Immunopathology of Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. marek.radkowski@wum.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroudCytokine response against hepatitis C virus (HCV) is likely to determine the natural course of infection as well as the outcome of antiviral treatment. However, the role of particular cytokines remains unclear. The current study analyzed activation of cytokine response in chronic hepatitis C patients undergoing standard antiviral treatment.

methodsTwenty-two patients were treated with pegylated interferon and ribavirin. Twenty-six different cytokine transcripts were measured quantitatively in peripheral blood mononuclear cells (PBMC) before and after therapy and correlated with therapy outcome as well as with clinical and liver histological data.

resultsWe found that patients who achieved sustained virological response (SVR) showed higher pretreatment cytokine response when compared to subjects in whom therapy was unsuccessful. The differentially expressed factors included IL-8, IL-16, TNF-α, GM-CSF, MCP-2, TGF-β, and IP-10. Serum ALT activity and/or histological grading also positively correlated with the expression of IL-1α, IL-4, IL-6, IL-10, IL-12, IL-15, GM-CSF, M-CSF, MCP-2 and TGF-β.

conclusionPretreatment activation of the immune system, as reflected by cytokines transcripts upregulation, positively correlates with treatment outcome and closely reflects liver inflammatory activity.

Indexed as

AdultAgedAntiviral AgentsCytokinesFemaleGene Expression ProfilingHepacivirusHepatitis C, ChronicHumansInterferon-alphaInterleukinsLeukocytes, MononuclearMaleMiddle AgedRibavirinTransforming Growth Factor betaAntiviral AgentsCytokinesInterferon-alphaInterleukinsRibavirinTransforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID26637466
PMCPMC4670510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.